Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods.
about
Screening for and verification of novel mutations associated with drug resistance in the HIV type 1 subtype B(') in ChinaUse of phylogenetics in the molecular epidemiology and evolutionary studies of viral infections.TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratoriesGenotypic testing for human immunodeficiency virus type 1 drug resistance.Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assaysGenotyping of B and non-B subtypes of human immunodeficiency virus type 1.Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations.Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.Evaluation of the editing process in human immunodeficiency virus type 1 genotyping.Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections.Genotypic antiretroviral resistance testing for human immunodeficiency virus type 1 integrase inhibitors by use of the TruGene sequencing system.Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.Description of two commercially available assays for genotyping of HIV-1.Performance characteristics of human immunodeficiency virus type 1 (HIV-1) genotyping systems in sequence-based analysis of subtypes other than HIV-1 subtype B.Genotypic prediction of human immunodeficiency virus type 1 tropism by use of plasma and peripheral blood mononuclear cells in the routine clinical laboratory.Modifications and substitutions of the RNA extraction module in the ViroSeq HIV-1 genotyping system version 2: effects on sensitivity and complexity of the assay.Kommerzielle Systeme zur Genotypisierung von humanen Immundefizienzviren Typ 1: Vergleich von ViroSeq (Abbott) und TruGene (Bayer). Commercially available assays for genotyping of human immunodeficiency virus type 1: Comparison of ViroSeq (Abbott) an
P2860
Q28485108-644B83F5-5E45-46A3-981E-05895B423DE0Q30387664-B9047199-942E-44ED-93EC-F5EB1BC5AC6CQ33824827-835029C4-0CE4-4422-A2E5-D9A2AFBB0ECDQ33906239-DE881116-F291-4961-947B-C469BC9C8F40Q34041819-68A3FA14-7B5C-4420-9C93-0E70438A9E0FQ34042412-0BCC78BF-A9F3-41B5-80D3-D4B8C28C0D39Q34746064-15A9B841-8257-4DC1-9EF2-CC84575A67D1Q35102225-D9D55E9B-E3C1-4220-8644-E5FE3EEABDEDQ35156231-24515EA8-77E7-4BFB-B7EC-80E370F49873Q35156934-E1A0EE08-22FA-4E7A-886A-5FC669C02718Q36550049-671E63FA-080A-4B15-9FB5-798CBD8D9B74Q36779718-ACFE4FB6-55F5-4F17-98DC-3F62DE52D2A2Q36994525-2A58149F-648D-4FFC-BAFA-5CAB66938C73Q37005868-244C3881-D3E3-4220-84CF-465255CCAF3AQ37216235-2E1C2F3A-2FFF-482F-B049-608B5C9C14BFQ37979704-F24E8211-477E-4096-A231-1D4DB2BF6FB8Q39735462-64BD66A4-8A2C-4E8A-9C90-541804152924Q42850302-5EF91201-E87A-4783-BAA5-F8D9CF107D8EQ53915102-AC6F81B5-7240-4154-95FC-449708A4B105Q57083225-46941253-6774-4738-91A2-90C06F04585F
P2860
Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Human immunodeficiency virus t ...... three sequence-based methods.
@ast
Human immunodeficiency virus t ...... three sequence-based methods.
@en
type
label
Human immunodeficiency virus t ...... three sequence-based methods.
@ast
Human immunodeficiency virus t ...... three sequence-based methods.
@en
prefLabel
Human immunodeficiency virus t ...... three sequence-based methods.
@ast
Human immunodeficiency virus t ...... three sequence-based methods.
@en
P2093
P2860
P1476
Human immunodeficiency virus t ...... three sequence-based methods.
@en
P2093
P2860
P304
P356
10.1128/JCM.39.6.2157-2165.2001
P407
P577
2001-06-01T00:00:00Z